Lynne A. Murray

9.5k total citations · 3 hit papers
72 papers, 7.0k citations indexed

About

Lynne A. Murray is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lynne A. Murray has authored 72 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 14 papers in Immunology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lynne A. Murray's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (34 papers), Neonatal Respiratory Health Research (11 papers) and Maternal Mental Health During Pregnancy and Postpartum (9 papers). Lynne A. Murray is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (34 papers), Neonatal Respiratory Health Research (11 papers) and Maternal Mental Health During Pregnancy and Postpartum (9 papers). Lynne A. Murray collaborates with scholars based in United States, United Kingdom and Sweden. Lynne A. Murray's co-authors include P. J. M. Cooper, Robert M. Strieter, Marie D. Burdick, John A. Belperio, Michael P. Keane, Ying Xue, Roderick J. Phillips, Kurt Hong, Cory M. Hogaboam and Dana A. Sinclair and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Lynne A. Murray

72 papers receiving 6.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

2004 813 citations Roderick J. Phillips, Marie D. Burdick et al. Journal of Clinical Investigation profile →
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

2004 770 citations Roderick J. Phillips, Marie D. Burdick et al. Journal of Clinical Investigation profile →
Origin of myofibroblasts in the fibrotic liver in mice

2014 411 citations Keiko Iwaisako, Chunyan Jiang et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynne A. Murray United States	37	2.9k	1.3k	1.3k	1.2k	996	72	7.0k
Angela Pistorio Italy	52	691 0.2×	706 0.5×	1.5k 1.2×	1.5k 1.2×	513 0.5×	259	9.0k
Nico Wulffraat Netherlands	54	761 0.3×	886 0.7×	3.2k 2.5×	2.2k 1.9×	350 0.4×	242	9.8k
Stefan Johansson Sweden	49	1.3k 0.4×	854 0.7×	629 0.5×	1.4k 1.2×	186 0.2×	143	8.6k
Kathryn Osann United States	54	1.8k 0.6×	455 0.4×	583 0.5×	1.2k 1.0×	168 0.2×	196	8.4k
Patrizia Rovere‐Querini Italy	54	969 0.3×	308 0.2×	4.4k 3.5×	2.6k 2.2×	1.1k 1.1×	225	11.5k
Naoko Kinukawa Japan	47	1.4k 0.5×	392 0.3×	876 0.7×	1.1k 1.0×	132 0.1×	191	6.5k
Michael Levy United States	49	297 0.1×	864 0.7×	1.3k 1.1×	1.1k 0.9×	470 0.5×	279	12.1k
Wendy Thomson United Kingdom	59	704 0.2×	636 0.5×	4.0k 3.1×	1.5k 1.3×	169 0.2×	283	10.5k
Anders Fasth Sweden	50	554 0.2×	492 0.4×	2.5k 2.0×	1.7k 1.5×	323 0.3×	224	7.4k
Willem A. Kamps Netherlands	54	902 0.3×	3.0k 2.4×	587 0.5×	2.2k 1.9×	452 0.5×	177	8.4k

Countries citing papers authored by Lynne A. Murray

Since Specialization

Citations

This map shows the geographic impact of Lynne A. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne A. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne A. Murray more than expected).

Fields of papers citing papers by Lynne A. Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne A. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne A. Murray. The network helps show where Lynne A. Murray may publish in the future.

Co-authorship network of co-authors of Lynne A. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne A. Murray. A scholar is included among the top collaborators of Lynne A. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne A. Murray. Lynne A. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Radwańska, Agata, Christopher T. Cottage, Antonio Piras, et al.. (2022). Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis. JCI Insight. 7(16). 37 indexed citations

Stegmayr, John, et al.. (2021). Targeting Alveolar Repair in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 65(4). 347–365. 34 indexed citations

Miranda, Elena, Rebecca Dunmore, Doris M. Rassl, et al.. (2020). Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects. Thorax. 75(9). 754–763. 30 indexed citations

Roux, Benoît, Eszter Csomor, Carol Feghali‐Bostwick, et al.. (2019). Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis. Scientific Reports. 9(1). 6020–6020. 20 indexed citations

Espíndola, Milena S., David M. Habiel, Ana Lúcia Coelho, et al.. (2018). Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 197(11). 1443–1456. 68 indexed citations

Stein, Alan, Elena Netsi, Peter J. Lawrence, et al.. (2018). Mitigating the effect of persistent postnatal depression on child outcomes through an intervention to treat depression and improve parenting: a randomised controlled trial. The Lancet Psychiatry. 5(2). 134–144. 83 indexed citations

Habiel, David M., Ana Camelo, Milena S. Espíndola, et al.. (2017). Divergent roles for Clusterin in Lung Injury and Repair. Scientific Reports. 7(1). 15444–15444. 28 indexed citations

Murray, Lynne A., Christopher Grainge, Peter Wark, & Darryl A. Knight. (2016). Use of biologics to treat acute exacerbations and manage disease in asthma, COPD and IPF. Pharmacology & Therapeutics. 169. 1–12. 7 indexed citations

Iwaisako, Keiko, Chunyan Jiang, Mingjun Zhang, et al.. (2014). Origin of myofibroblasts in the fibrotic liver in mice. Proceedings of the National Academy of Sciences. 111(32). E3297–305. 411 indexed citations breakdown →

10.

Ellson, Christian D., Rebecca Dunmore, Cory M. Hogaboam, Matthew A. Sleeman, & Lynne A. Murray. (2014). Danger-Associated Molecular Patterns and Danger Signals in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 51(2). 163–168. 52 indexed citations

11.

Reilkoff, Ronald A., Hong Peng, Lynne A. Murray, et al.. (2012). Semaphorin 7a+ Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 187(2). 180–188. 97 indexed citations

12.

Oh, Chad K., Lynne A. Murray, & Néstor A. Molfino. (2012). Smoking and Idiopathic Pulmonary Fibrosis. Pulmonary Medicine. 2012. 1–13. 74 indexed citations

13.

Ekert, Jason E., et al.. (2011). Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes. PubMed. 4(1). 23–23. 58 indexed citations

14.

Murray, Lynne A.. (2011). Commonalities between the pro-fibrotic mechanisms in COPD and IPF. Pulmonary Pharmacology & Therapeutics. 25(4). 276–280. 11 indexed citations

15.

Hackett, Tillie‐Louise, Stephanie Warner, Dorota Stefanowicz, et al.. (2009). Induction of Epithelial–Mesenchymal Transition in Primary Airway Epithelial Cells from Patients with Asthma by Transforming Growth Factor-β1. American Journal of Respiratory and Critical Care Medicine. 180(2). 122–133. 316 indexed citations

16.

Murray, Lynne A., Darryl A. Knight, Rochelle L. Argentieri, et al.. (2008). Deleterious Role of TLR3 during Hyperoxia-induced Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 178(12). 1227–1237. 63 indexed citations

17.

Burdick, Marie D., Lynne A. Murray, Michael P. Keane, et al.. (2004). CXCL11 Attenuates Bleomycin-induced Pulmonary Fibrosis via Inhibition of Vascular Remodeling. American Journal of Respiratory and Critical Care Medicine. 171(3). 261–268. 135 indexed citations

18.

Phillips, Roderick J., Marie D. Burdick, Kurt Hong, et al.. (2004). Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. Journal of Clinical Investigation. 114(3). 438–446. 813 indexed citations breakdown →

19.

Murray, Lynne A., Matt Woolgar, Joseph Murray, & Peter Cooper. (2003). Self-exclusion from health care in women at high risk for postpartum depression. Journal of Public Health. 25(2). 131–137. 60 indexed citations

20.

Barrett, Jon, Lynne A. Murray, & H. N. Macdonald. (1989). Darier's disease localized to the vulva. Case report. BJOG An International Journal of Obstetrics & Gynaecology. 96(8). 997–999. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact